News

A clinical trial for semaglutide, the active ingredient in Ozempic, found that it improved blood sugar control in people with ...
In a small cell therapy trial, 10 out of 12 people with type 1 diabetes no longer needed supplemental insulin, even a year after treatment.
Children with diabetes who inhaled their mealtime doses of insulin did just as well as those who injected insulin under the ...
Medtronic, Beta Bionics and Tandem Diabetes Care showcased planned patch pumps at the conference, while Senseonics shared ...
The chief product and customer experience officer said Insulet has seen an uptick in users with Type 2 diabetes since ...
In a trial, the daily GLP-1 pill showed "significant" results and similar side effects to injectable GLP-1 drugs like Ozempic ...
Tsimikas, vice president of San Diego’s Scripps Whittier Diabetes Institute, helped deliver positive news for the estimated 7 million Americans who take ...
The once-weekly insulin analog lowered A1c as effectively as once-daily formulations in three new trials in type 2 diabetes.
Why FDA approval of new HIV prevention drug is a big deal The U.S. Food and Drug Administration has approved the drug lenacapavir as a twice-yearly injection to prevent HIV.
Food and Drug Administration Commissioner Marty Makary announces the FDA's intent to phase out the use of petroleum-based synthetic dyes in the nation's food supply during a press conference ...
June 18 (UPI) -- The Food and Drug Administration has approved a new drug that could prevent HIV infections with just two shots every year and possibly eradicate the disease. The drug's scientific ...
Food and Drug Administration Commissioner Marty Makary said the agency will aim to review select drugs in one to two months. FDA's long-standing accelerated approval program generally issues ...